Clinical Trials on Metastatic Beast Cancer
Total 57511 results
-
Teva PharmaCompletedMetastatic Breast CancerBelgium
-
R-PharmCompletedMetastatic Breast CancerItaly, Turkey, Spain, France, Greece
-
PTC TherapeuticsUnited States Department of DefenseCompletedMetastatic Breast CancerUnited States
-
Centro Universitario contra el CáncerCompleted
-
Tianjin Medical University Cancer Institute and...UnknownMetastatic Breast CancerChina
-
Hoosier Cancer Research NetworkSanofi; Hoffmann-La Roche; Walther Cancer InstituteCompletedMetastatic Breast CancerUnited States
-
Jewish General HospitalTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Hellenic Oncology Research GroupCompletedMetastatic Breast CancerGreece
-
Thomas HatschekCompletedMetastatic Breast CancerSweden
-
University of OklahomaCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; AmgenCompletedMetastatic Breast CancerUnited States
-
Cancer Trials IrelandCompletedMetastatic Breast CancerIreland
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
University of PisaCompleted
-
University of ChicagoGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterBaylor College of Medicine; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaboratorsCompletedMetastatic Breast CancerUnited States
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownMetastatic Breast CancerKorea, Republic of
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
China Medical University HospitalTerminated
-
Accelerated Community Oncology Research NetworkHoffmann-La Roche; AstraZenecaCompletedMetastatic Breast CancerUnited States
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsWithdrawn
-
Chugai PharmaceuticalCompleted
-
BionovoCompletedMetastatic Breast Cancer
-
BionovoUnknownMetastatic Breast CancerUnited States
-
National Cancer Center, KoreaCompletedBreast Cancer MetastaticKorea, Republic of
-
TTY BiopharmUnknownMetastatic Breast CancerTaiwan
-
German Breast GroupCompleted
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
ARCAGY/ GINECO GROUPCompleted
-
National Cancer Center, KoreaCompleted
-
Hellenic Cooperative Oncology GroupTerminatedMetastatic Breast CancerGreece
-
PfizerCompleted
-
Ludwig-Maximilians - University of MunichCompleted
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
YM BioSciencesCompletedMetastatic Breast CancerSerbia
-
Eli Lilly and CompanyCompleted
-
University of Colorado, DenverCancer League of ColoradoRecruiting
-
Lycera Corp.CompletedCancerUnited States
-
Massachusetts General HospitalCompletedCancer | Metastatic CancerUnited States
-
Changhai HospitalNot yet recruitingBreast Neoplasms | Metastatic Breast Cancer | Treatment | Survival
-
Institut CurieRecruitingHER2-negative Metastatic Breast CancerFrance
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Institut CurieRain Oncology IncTerminatedAdvanced or Metastatic Breast CancerFrance
-
Dizal PharmaceuticalsActive, not recruitingBreast Cancer MetastaticChina, United States